User menu

A novel inhibitor of plasminogen activator inhibitor-1 provides antithrombotic benefits devoid of bleeding effect in nonhuman primates

Bibliographic reference Izuhara, Yuko ; Yamaoka, Nagahisa ; Kodama, Hidehiko ; Dan, Takashi ; Takizawa, Shunya ; et. al. A novel inhibitor of plasminogen activator inhibitor-1 provides antithrombotic benefits devoid of bleeding effect in nonhuman primates. In: Journal of Cerebral Blood Flow and Metabolism, Vol. 30, no. 5, p. 904-912 (2010)
Permanent URL http://hdl.handle.net/2078.1/33912
  1. Alexandrov A. V., Grotta J. C., Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator, 10.1212/wnl.59.6.862
  2. Bernstein Frances C., Koetzle Thomas F., Williams Graheme J.B., Meyer Edgar F., Brice Michael D., Rodgers John R., Kennard Olga, Shimanouchi Takehiko, Tasumi Mitsuo, The protein data bank: A computer-based archival file for macromolecular structures, 10.1016/s0022-2836(77)80200-3
  3. Caplan L. R., Intracranial branch atheromatous disease: A neglected, understudied, and underused concept, 10.1212/wnl.39.9.1246
  4. Carmeliet P, Stassen J M, Schoonjans L, Ream B, van den Oord J J, De Mol M, Mulligan R C, Collen D, Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis., 10.1172/jci116893
  5. Derex L, Nighoghossian N, Intracerebral haemorrhage after thrombolysis for acute ischaemic stroke: an update, 10.1136/jnnp.2007.133371
  6. Devin J. K, Johnson J. E, Eren M., Gleaves L. A, Bradham W. S, Bloodworth J. R, Vaughan D. E, Transgenic overexpression of plasminogen activator inhibitor-1 promotes the development of polycystic ovarian changes in female mice, 10.1677/jme-06-0057
  7. Eitzman D T, McCoy R D, Zheng X, Fay W P, Shen T, Ginsburg D, Simon R H, Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene., 10.1172/jci118396
  8. Eitzman DT, Blood, 96, 4212 (2000)
  9. EREN M., GLEAVES L. A., ATKINSON J. B., KING L. E., DECLERCK P. J., VAUGHAN D. E., Reactive site-dependent phenotypic alterations in plasminogen activator inhibitor-1 transgenic mice, 10.1111/j.1538-7836.2007.02587.x
  10. Gardell S. J., Krueger J. A., Antrilli T. A., Elokdah H., Mayer S., Orcutt S. J., Crandall D. L., Vlasuk G. P., Neutralization of Plasminogen Activator Inhibitor I (PAI-1) by the Synthetic Antagonist PAI-749 via a Dual Mechanism of Action, 10.1124/mol.107.037010
  11. Goto Junichi, Kataoka Ryoichi, Muta Hajime, Hirayama Noriaki, ASEDock-Docking Based on Alpha Spheres and Excluded Volumes, 10.1021/ci700352q
  12. Grotta J. C., Welch K. M. A., Fagan S. C., Lu M., Frankel M. R., Brott T., Levine S. R., Lyden P. D., Clinical Deterioration Following Improvement in the NINDS rt-PA Stroke Trial, 10.1161/01.str.32.3.661
  13. Ha Hunjoo, Oh Eun Y., Lee Hi B., The role of plasminogen activator inhibitor 1 in renal and cardiovascular diseases, 10.1038/nrneph.2009.15
  14. Izuhara Y., Takahashi S., Nangaku M., Takizawa S., Ishida H., Kurokawa K., van Ypersele de Strihou C., Hirayama N., Miyata T., Inhibition of Plasminogen Activator Inhibitor-1: Its Mechanism and Effectiveness on Coagulation and Fibrosis, 10.1161/atvbaha.107.157479
  15. Maeda Masashi, Moriguchi Akira, Mihara Kayoko, Aoki Toshiaki, Takamatsu Hiroyuki, Matsuoka Nobuya, Mutoh Seitaro, Goto Toshio, FK419, a Nonpeptide Platelet Glycoprotein IIb/IIIa Antagonist, Ameliorates Brain Infarction Associated with Thrombotic Focal Cerebral Ischemia in Monkeys: Comparison with Tissue Plasminogen Activator, 10.1038/sj.jcbfm.9600013
  16. Maeda Masashi, Takamatsu Hiroyuki, Furuichi Yasuhisa, Noda Akihiko, Awaga Yuji, Tatsumi Mitsuyoshi, Yamamoto Masashi, Ichise Rikiya, Nishimura Shintaro, Matsuoka Nobuya, Characterization of a novel thrombotic middle cerebral artery occlusion model in monkeys that exhibits progressive hypoperfusion and robust cortical infarction, 10.1016/j.jneumeth.2005.01.019
  17. MEHTA R., SHAPIRO A. D., Plasminogen activator inhibitor type 1 deficiency : PAI-1 DEFICIENCY, 10.1111/j.1365-2516.2008.01834.x
  18. Morishima Y, Thromb Haemost, 78, 1366 (1997)
  19. Nicholas Susanne B., Aguiniga Elsa, Ren Yuelan, Kim Jason, Wong Joyce, Govindarajan Nalini, Noda Masakuni, Wang Wei, Kawano Yasuko, Collins Alan, Hsueh Willa A., Plasminogen activator inhibitor-1 deficiency retards diabetic nephropathy, 10.1111/j.1523-1755.2005.00207.x
  20. Nighoghossian N., Hermier M., Adeleine P., Blanc-Lasserre K., Derex L., Honnorat J., Philippeau F., Dugor J.F., Froment J.C., Trouillas P., Old Microbleeds Are a Potential Risk Factor for Cerebral Bleeding After Ischemic Stroke: A Gradient-Echo T2*-Weighted Brain MRI Study, 10.1161/hs0302.104615
  21. Recommendations for Standards Regarding Preclinical Neuroprotective and Restorative Drug Development, 10.1161/01.str.30.12.2752
  22. Tissue Plasminogen Activator for Acute Ischemic Stroke, 10.1056/nejm199512143332401
  23. Group T. N. t-P. S. S., Intracerebral Hemorrhage After Intravenous t-PA Therapy for Ischemic Stroke, 10.1161/01.str.28.11.2109
  24. Umemura K., Wada K., Uematsu T., Nakashima M., Evaluation of the combination of a tissue-type plasminogen activator, SUN9216, and a thromboxane A2 receptor antagonist, vapiprost, in a rat middle cerebral artery thrombosis model, 10.1161/01.str.24.7.1077
  25. Vaughan Douglas, De Taeye Bart, Eren Mesut, PAI-1 Antagonists: Predictable Indications and Unconventional Applications, 10.2174/138945007781662364
  26. Weisberg A. D., Pharmacological Inhibition and Genetic Deficiency of Plasminogen Activator Inhibitor-1 Attenuates Angiotensin II/Salt-Induced Aortic Remodeling, 10.1161/01.atv.0000152356.85791.52
  27. Wong K.S., Chan Y.L., Liu J.Y., Gao S., Lam W. W.M., Asymptomatic microbleeds as a risk factor for aspirin-associated intracerebral hemorrhages, 10.1212/01.wnl.0000046583.40125.20